클렌 (CLNN) 주가

클렌(CLNN)는 NAS에 상장된 Consumer Defensive · Packaged Foods 기업입니다. 현재가 $4.35 (+4.82%), 시가총액 $88.17M, 52주 범위 $2.37 ~ $12.50.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic…

핵심 지표

• 현재가: $4.35 (+4.82%)
• 시가총액: $88.17M
• 52주 최저~최고: $2.37 ~ $12.50
• 섹터: Consumer Defensive
• 산업: Packaged Foods
• 거래소: NAS

클렌의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

클렌 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (4.5 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 7.83
• 순이익률: 0.00%

자주 묻는 질문